Cronus Pharma LLC is voluntarily recalling two lots of its veterinary sedative and anesthesia due to the presence of visible particles in the solution, according to the Food and Drug Administration.
The purpose of the present study was to evaluate the sedative, analgesic, and behavioral effects of nalbuphine-xylazine (NX) and nalbuphine-midazolam (NM) combinations for neuroleptanalgesia in dogs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results